NextPlat Corporation said it expects approximately $55 million in revenue for 2025 and anticipates sequential improvement in key financial and operational metrics in fourth-quarter 2025 versus third-quarter 2025. The company expects 340B revenue to rise more than 90% sequentially in Q4 2025, with total prescription volume up about 7%. NextPlat also forecast consolidated gross margin expansion of about 20% to 25% in Q1 2026 as it shifts toward higher-margin contracted services, with further improvement expected through 2026.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NextPlat Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: FL95056) on February 25, 2026, and is solely responsible for the information contained therein.
Comments